Effect of Subcutaneous Spesolimab on the Prevention of Generalized Pustular Psoriasis Flares Over 48 weeks: Subgroup Analyses from the Effisayil 2 Trial . (2023). SKIN The Journal of Cutaneous Medicine, 7(6), s245. https://doi.org/10.25251/skin.7.supp.245